DTIL - Precision Biosciences Inc
IEX Last Trade
10.82
0.270 2.495%
Share volume: 63,847
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$10.55
0.27
2.56%
Fundamental analysis
30%
Profitability
10%
Dept financing
20%
Liquidity
64%
Performance
45%
Performance
5 Days
12.28%
1 Month
13.93%
3 Months
-15.13%
6 Months
-41.38%
1 Year
-26.23%
2 Year
-77.19%
Key data
Stock price
$10.82
DAY RANGE
$10.42 - N/A
52 WEEK RANGE
$8.25 - $19.43
52 WEEK CHANGE
-$0.26
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Matthew Kane
Region: US
Website: http://precisionbiosciences.com/
Employees: 218
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://precisionbiosciences.com/
Employees: 218
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
precision biosciences, inc. is a biotechnology company located in durham, north carolina, united states.
Recent news